Text Size

A A A

Search


 

Home | Clinical Trials

FDA Approved Drugs » 1998
Medical Areas: Neurology | Family Medicine | Genetic Disease

View By:Year | Company | Conditions | Therapeutic Areas | Drug Names

Clonazepam

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Watson Pharmaceuticals
Approval Status: Approved January 1998
Treatment Area: anticonvulsant

General Information

Clonazepam has been approved as an anticonvulsant to be manufactured in 0.5mg, 1mg and 2mg tablets. It is the generic equivalent of Roche Laboratories' Klonopin.


 Back to Top | Printer Friendly Version

Get Involved

Stroke and You

Our Mission Statement

National Stroke Association’s mission is to reduce the incidence and impact of stroke by developing compelling education and programs focused on prevention, treatment, rehabilitation and support for all impacted by stroke.

National Stroke Association

1-800-STROKES
1-800-787-6537
9707 E. Easter Lane, Suite B
Centennial, CO 80112
info@stroke.org